These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
4. A model for human leukocyte antigen-matched donor-swap transplantation in India. Basu G; Daniel D; Rajagopal A; Neelakantan N; John GT Transplantation; 2008 Mar; 85(5):687-92. PubMed ID: 18337661 [TBL] [Abstract][Full Text] [Related]
5. Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation. Gerrits JH; van de Wetering J; Drabbels JJ; IJzermans JN; Claas FH; Weimar W; van Besouw NM Clin Transplant; 2009; 23(5):740-7. PubMed ID: 19563488 [TBL] [Abstract][Full Text] [Related]
6. Use of PCR and PCR-SSP for detection of urinary donor-origin DNA in renal transplant recipients with acute rejection. Zhang Z; Ohkohchi N; Okazaki H; Guo Y Chin Med J (Engl); 2003 Feb; 116(2):191-4. PubMed ID: 12775227 [TBL] [Abstract][Full Text] [Related]
7. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants. Sasaki N; Idica A; Hall B; Terasaki PI Clin Transpl; 2008; ():241-52. PubMed ID: 19711515 [TBL] [Abstract][Full Text] [Related]
8. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies. Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897 [TBL] [Abstract][Full Text] [Related]
9. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation. Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605 [TBL] [Abstract][Full Text] [Related]
11. Allosensitization to HLA and MICA is an important measure of renal graft outcome. Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK Clin Transpl; 2007; ():211-7. PubMed ID: 18637472 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against MICA antigens and kidney-transplant rejection. Zou Y; Stastny P; Süsal C; Döhler B; Opelz G N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098 [TBL] [Abstract][Full Text] [Related]
13. A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors. Pirri A; Contieri FC; Benvenutti R; Bicalho Mda G Transpl Immunol; 2009 Jan; 20(3):143-9. PubMed ID: 18926911 [TBL] [Abstract][Full Text] [Related]
14. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients. Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862 [TBL] [Abstract][Full Text] [Related]
15. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation. Li X; Ishida H; Yamaguchi Y; Tanabe K Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618 [TBL] [Abstract][Full Text] [Related]
16. A multiplex bead array analysis to monitor donor-specific cytokine responses after withdrawal of immunosuppression in HLA-identical living related kidney transplant patients. Gerrits JH; van de Wetering J; van Beelen E; Claas FH; Weimar W; van Besouw NM Transplant Proc; 2009 Jun; 41(5):1577-82. PubMed ID: 19545683 [TBL] [Abstract][Full Text] [Related]
17. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch. Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518 [TBL] [Abstract][Full Text] [Related]
18. Stable T-cell reactivity after successful tapering of azathioprine in HLA-identical living-related kidney transplant recipients despite minor histocompatibility antigen mismatches. Gerrits JH; van de Wetering J; Postma S; Drabbels JJ; Vaessen LM; IJzermans JN; Rischen J; Claas FH; Weimar W; van Besouw NM Nephrol Dial Transplant; 2007 Feb; 22(2):353-61. PubMed ID: 17124279 [TBL] [Abstract][Full Text] [Related]
19. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up. Lachmann N; Terasaki PI; Schönemann C Clin Transpl; 2006; ():171-99. PubMed ID: 18365377 [TBL] [Abstract][Full Text] [Related]
20. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine. Thorogood J; Schreuder GM; Persijn GG; van Rood JJ Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839 [No Abstract] [Full Text] [Related] [Next] [New Search]